NIM-1324

N/A

Report date: 2024/01/08 16:50:28
NME

Base Information

Drug NameNIM-1324
Drug Alias NameLABP-104NIM-1324BT-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanC-like protein 2 agonists
TargetsLanC-like protein 2
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLandos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNImmune Biopharma IncLandos Biopharma Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A